Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Rein Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $144.10M | $144.10M - $144.10M | $0.00 | $0.55 | 1 |
| Dec 2029 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.57 | 0 |
| Dec 2028 | $0.00 | $0.00 - $0.00 | $0.00 | -$0.66 | 0 |
| Dec 2027 | $127.66M | $127.66M - $127.66M | $0.00 | -$0.50 | 1 |
| Dec 2026 | $69.76M | $69.76M - $69.76M | $0.00 | -$0.53 | 1 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.445 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.745 | 0 |